VictorMPriegoMD

Oncology • Bethesda, MD

Physician

Join to view full profile

Dr. Priego is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Priego's full profile

Already have an account?

Office
6410 Rockledge Dr
Suite 660
Bethesda, MD 20817
Phone+1 301-571-0019

Fax+1 301-571-0988

Education & Training

Georgetown University HospitalFellowship, Medical Oncology, 1978 - 1985
Providence HospitalResidency, Internal Medicine, 1977 - 1979
Universidad Autonoma de GuadalajaraClass of 1974

Certifications & Licensure

MD State Medical License 1979 - 2025
DC State Medical License 1984 - 2024
NJ State Medical License 2015 - 2019
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Top Doctors:Washington DC Area Castle Connolly, 2012
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
Completed
Phase 3

Publications & Presentations

PubMed

8 citations
Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).
John D. Hainsworth, David M. Waterhouse, Kent C. Shih, Ralph V. Boccia, Victor M. Priego
Lung Cancer. 2018-04-01
18 citations
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
Denise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky
Breast Cancer Research and Treatment. 2017-05-15
117 citations
Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study
Adrian C. Newland, Bertrand Godeau, Victor M. Priego, Jean-François Viallard, Maria Fernanda Lopez Fernandez
British Journal of Haematology. 2016-01-01

Press Mentions

American Oncology Network Physicians Research Presented at 64th ASH Annual Meeting & ExpositionDecember 14th, 2022
American Oncology Network Physicians Research Presented at ASCO22June 13th, 2022
4 Nutrition Tips During Breast Cancer TreatmentJune 11th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Other Languages

Spanish